| Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults MA Brockman, F Mwimanzi, HR Lapointe, Y Sang, O Agafitei, PK Cheung, ... The Journal of infectious diseases 225 (7), 1129-1140, 2022 | 102 | 2022 |
| Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy ZL Brumme, F Mwimanzi, HR Lapointe, PK Cheung, Y Sang, MC Duncan, ... npj Vaccines 7 (1), 28, 2022 | 84 | 2022 |
| Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine but strong initial responses to a third dose F Mwimanzi, HR Lapointe, PK Cheung, Y Sang, F Yaseen, ... The Journal of infectious diseases 226 (6), 983-994, 2022 | 40 | 2022 |
| People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses HR Lapointe, F Mwimanzi, PK Cheung, Y Sang, F Yaseen, ... medRxiv, 2022 | 33 | 2022 |
| Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5 SW Jin, FM Mwimanzi, JK Mann, MB Bwana, GQ Lee, CJ Brumme, ... PLoS pathogens 16 (9), e1008813, 2020 | 30 | 2020 |
| People with human immunodeficiency virus receiving suppressive antiretroviral therapy show typical antibody durability after dual coronavirus disease 2019 vaccination and … HR Lapointe, F Mwimanzi, PK Cheung, Y Sang, F Yaseen, ... The Journal of Infectious Diseases 227 (7), 838-849, 2023 | 18 | 2023 |
| Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy HR Lapointe, F Mwimanzi, PK Cheung, Y Sang, F Yaseen, S Speckmaier, ... Aids 37 (5), 709-721, 2023 | 17 | 2023 |
| Resistance of major histocompatibility complex class B (MHC-B) to Nef-mediated downregulation relative to that of MHC-A is conserved among primate lentiviruses and influences … F Mwimanzi, M Toyoda, M Mahiti, JK Mann, JN Martin, D Bangsberg, ... Journal of virology 92 (1), 10.1128/jvi. 01409-17, 2018 | 15 | 2018 |
| Relative resistance of HLA-B to downregulation by naturally occurring HIV-1 Nef sequences M Mahiti, M Toyoda, X Jia, XT Kuang, F Mwimanzi, P Mwimanzi, ... MBio 7 (1), 10.1128/mbio. 01516-15, 2016 | 14 | 2016 |
| SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive ART PK Cheung, HR Lapointe, Y Sang, S Ennis, F Mwimanzi, S Speckmaier, ... Aids, 10.1097, 2022 | 9 | 2022 |
| Serial infection with SARS-CoV-2 Omicron BA. 1 and BA. 2 following three-dose COVID-19 vaccination HR Lapointe, F Mwimanzi, PK Cheung, Y Sang, F Yaseen, R Kalikawe, ... Frontiers in Immunology 13, 947021, 2022 | 8 | 2022 |
| Association between a naturally arising polymorphism within a functional region of HIV-1 Nef and disease progression in chronic HIV-1 infection SC Meribe, Z Hasan, M Mahiti, F Mwimanzi, M Toyoda, M Mori, ... Archives of virology 160, 2033-2041, 2015 | 7 | 2015 |
| Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy. medRxiv 2021 ZL Brumme, F Mwimanzi, HR Lapointe, P Cheung, Y Sang, MC Duncan, ... CrossRef][PubMed], 0 | 6 | |
| Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine F Mwimanzi, HR Lapointe, PK Cheung, Y Sang, F Yaseen, R Kalikawe, ... medRxiv, 2022.08. 08.22278494, 2022 | 5 | 2022 |
| Older adults mount less durable humoral responses to a two-dose COVID-19 mRNA vaccine regimen, but strong initial responses to a third dose F Mwimanzi, H Lapointe, PK Cheung, Y Sang, F Yaseen, G Umviligihozo, ... medRxiv, 2022.01. 06.22268745, 2022 | 5 | 2022 |
| Relative resistance of HLA‐B to downregulation by naturally occurring HIV‐1 Nef sequences. mBio. 2016; 7 (1): e01516‐15 M Mahiti, M Toyoda, X Jia, XT Kuang, F Mwimanzi, P Mwimanzi, ... Published, 2016 | 5 | 2016 |
| T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy S Datwani, R Kalikawe, R Waterworth, FM Mwimanzi, R Liang, Y Sang, ... Viruses 16 (5), 661, 2024 | 2 | 2024 |
| Impact of age and severe acute respiratory syndrome coronavirus 2 breakthrough infection on humoral immune responses after three doses of coronavirus disease 2019 mRNA vaccine F Mwimanzi, HR Lapointe, PK Cheung, Y Sang, F Yaseen, R Kalikawe, ... Open Forum Infectious Diseases 10 (3), ofad073, 2023 | 2 | 2023 |
| Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults S Datwani, R Kalikawe, F Mwimanzi, S Speckmaier, R Liang, Y Sang, ... Pathogens and Immunity 8 (1), 117, 2023 | 2 | 2023 |
| An HIV-1 Nef genotype that diminishes immune control mediated by protective human leucocyte antigen alleles F Mwimanzi, I Ngare, M Toyoda, M Mori, J Mann, T Ndung’u, P Goulder, ... Aids 34 (9), 1325-1330, 2020 | 1 | 2020 |
